Gene Therapy Market to Reach $46.5 Bn, Globally, by 2030 at 22.8% CAGR: Allied Market Research

Increase in the prevalence of chronic disorders, rise in government support, and ethical acceptance of gene therapy for cancer treatment drive the growth of the global gene therapy market.

PORTLAND, Ore., May 3, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Gene Therapy Market by Vector Type (Viral Vector, Non Viral Vector), by Therapy (In Vivo Therapy, Ex Vivo Therapy), by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors, Others), by Application (Oncological Disorders, Rare Diseases, Neurological Disorders, Other Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2030." According to the report, the global gene therapy industry was estimated at $6.0 billion in 2020, and is anticipated to hit $46.5 billion by 2030, registering a CAGR of 22.8% from 2021 to 2030.

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/2841

Drivers, restraints, and opportunities-

Increase in the prevalence of chronic disorders, rise in government support, and ethical acceptance of gene therapy for cancer treatment drive the growth of the global gene therapy market. On the other hand, high cost of gene therapies restrains the growth to some extent. However, the presence of advanced healthcare infrastructure is anticipated to pave the way for lucrative opportunities in the industry.

Covid-19 scenario-

• A steep decline in the number of cancer patients visiting clinics and hospitals for gene therapy led to decreased demand for gene therapy products across the world, which had a negative impact on the global market.
• However, the market is anticipated to revive soon, since the global situation has started getting back to normalcy.

The antigen segment to maintain its lion's share-

On the basis of gene type, the antigen segment accounted for the highest market share in 2020, generating nearly one-fourth of the global gene therapy market. Rise in the prevalence of diseases such as autoimmune diseases & cancer and increase in R&D activities associated with antigen-based gene therapies propel the growth of the segment. The deficiency segment, however, is anticipated to cite the fastest CAGR of 26.0% from 2021 to 2030.

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2841

The oncological disorders segment to lead the trail-

On the basis of application, the oncological disorders segment generated the highest share in 2020, holding more than two-fifths of the global gene therapy market. The same segment is also expected to cite the fastest CAGR of 23.5% from 2021 to 2030. Increase in the prevalence of cancer and availability of diverse gene therapy products that can be used to treat cancer fuel the segment growth.

North America to dominate by 2030-

On the basis of region, North America contributed to the major market share in terms of revenue 2020, holding nearly half of the global gene therapy market. The Asia-Pacific region, simultaneously, is projected to cite the fastest CAGR of 25.4% from 2021 to 2030. This is attributed to the facts such as rise in the prevalence of chronic diseases, increase in healthcare expenditure, developments in healthcare infrastructure, availability of reimbursements, and the presence of major market players in the province.

Prominent market players-

• Gilead Sciences
• Orchard Therapeutics.
• Bristol-Myers Squibb.
• Therapeutics plc
• Adverum Biotechnologies, Inc.
• Amgen Inc.
• Jazz Pharmaceuticals,
• Shenzhen SiBiono Genentech
• Adaptimmune
• Novartis AG
• Shanghai Sunway Biotech Co., Ltd.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Cell Therapy Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Oncology/Cancer Drugs Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Telemedicine Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Surgical Robotics Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Surgical Equipment Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Advanced Wound Care Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

In Vitro Diagnostics (IVD) Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Sleep Aids Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Cryotherapy Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Electronic Health Records (EHR) Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg